Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,887,024
+$460,212 QoQ
Shares Held
23,180
+4.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#1,492
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SMITH, MOORE & CO. holds $27,430,178 across 9 Drug Manufacturers - General names. JNJ ranks #3 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
28,543 | $7,182,560 | |
| 2 | LLY |
ELI LILLY & Co
|
5,912 | $7,091,030 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
23,180 | $5,887,024 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,976 | $3,080,916 | |
| 5 | AMGN |
Amgen Inc
|
4,729 | $1,712,465 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,730 | $906,362 | |
| 7 | PFE |
Pfizer Inc
|
32,201 | $775,400 | |
| 8 | AZN |
Astrazeneca PLC
|
2,644 | $501,355 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,887,024 | 23,180 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,426,812 | 22,201 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $4,607,534 | 22,264 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $4,465,099 | 24,081 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,640,185 | 23,831 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,793,258 | 22,873 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,383,818 | 23,398 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,904,025 | 24,090 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,636,168 | 24,878 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,854,457 | 24,366 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,949,064 | 25,195 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,027,383 | 25,858 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $4,043,653 | 24,430 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,724,030 | 24,026 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,182,188 | 23,675 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,850,721 | 23,572 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,208,407 | 23,708 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,284,358 | 24,174 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,100,376 | 23,969 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $3,842,408 | 23,792 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,992,968 | 24,238 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,976,448 | 24,195 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,703,151 | 23,530 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,604,682 | 24,212 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,811,334 | 19,991 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $3,067,392 | 23,392 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||